Evercyte proudly introduces the EVscale™ platform
Evercyte proudly introduces the EVscale™ platform April 29th, 2024, Vienna, Austria The collaborative effort of Evercyte, Phoenestra, and TAmiRNA has yielded the EVscale™ platform,
Newly published study featuring our PODO/TERT256 cell line
Recent publication showcasing our PODO/TERT256 telomerized cell line February 16th, 2024, Vienna, Austria Our telomerized human podocyte cells (PODO/TERT256) were employed in an
Evercyte contributing to reduce animal testing at key events
Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at
Evercyte Showcases Expertise in Japan’s Pharma Landscape
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our
Participation to the first MOVE symposium
We participated to the first MOVE symposium in Malaga, Spain October 27th, 2023, Vienna, Austria We participated to the first MOVE
Participation to the Small New World 2.0 meeting
We participated to the Small New World 2.0 meeting in Graz, Austria September 12th, 2023, Vienna, Austria We participated to the
RPTEC/TERT1 relevant kidney-on-a-chip model
Collaboration with Nortis to establish human kidney-on-a-chip model August 4th, 2023. Vienna, Austria Our telomerized Human Renal Proximal Tubular Epithelial cells (RPTEC/TERT1) were used in collaboration with
Participation in the CHANGE project
We are proud to announce our participation in the CHANGE project May 4th, 2023, Vienna, Austria The CHANGE project focuses on
Wharton’s jelly MSC-EVs
Recent publication showcasing our telomerized Wharton's jelly-MSCs as EV-cell factories April 4th, 2023, Vienna, AustriaOur telomerized Wharton's jelly-derived MSCs (WJ-MSC/TERT273)
The LifeSaver project film
The LifeSaver project film November 30, 2022, Vienna, Austria Evercyte is a proud participant in the LifeSaver Project